Covered recipient · General Payments record
PRAMILA KHATRI THAPA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$902.66
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $288.16 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $114.60 | 7 |
| Lilly USA, LLC | $95.36 | 6 |
| Janssen Pharmaceuticals, Inc | $24.00 | 1 |
| SANOFI PASTEUR INC. | $22.64 | 1 |
| DEXCOM, INC. | $18.38 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $13.18 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086304501 | CMS |
| Dexcom, Inc. | $18.38 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153328383 | CMS |
| Janssen Pharmaceuticals, Inc | $24.00 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078100686 | CMS |
| Lilly USA, LLC | $17.10 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135926624 | CMS |
| Lilly USA, LLC | $13.29 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135921732 | CMS |
| Lilly USA, LLC | $19.20 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135878485 | CMS |
| Lilly USA, LLC | $14.07 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135926622 | CMS |
| Lilly USA, LLC | $15.50 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135878488 | CMS |
| Lilly USA, LLC | $16.20 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135922114 | CMS |
| Novo Nordisk Inc | $16.23 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108571040 | CMS |
| Novo Nordisk Inc | $17.33 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108572688 | CMS |
| Novo Nordisk Inc | $14.98 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565855 | CMS |
| Novo Nordisk Inc | $13.39 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108569722 | CMS |
| Novo Nordisk Inc | $15.25 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568009 | CMS |
| Novo Nordisk Inc | $17.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570644 | CMS |
| Novo Nordisk Inc | $20.04 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108573626 | CMS |
| SANOFI PASTEUR INC. | $22.64 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128753839 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.